BioCentury
ARTICLE | Clinical News

KBPA101 regulatory update

July 31, 2006 7:00 AM UTC

The EC granted Orphan Drug designation to KBPA101 to treat pneumonia caused by serotype O11 Pseudomonas aeruginosa. The human monoclonal antibody against P. aeruginosa is in Phase II testing. ...